Seoulin Bioscience Co.,Ltd. (KOSDAQ: A038070)
Health Care · Biotechnology · KR
₩4,230.00
-7.24% today · -37.8% 1Y
Seoulin Bioscience Co.,Ltd. (KOSDAQ: A038070) operates in the Biotechnology industry within the Health Care sector. The company is valued at $27.57M.
Over the last twelve months the share price has lost 37.8%, trading between 3.60K and 7.76K.
Tweenvest scores Seoulin Bioscience Co.,Ltd. across four factors: quality 65/100, value 53/100, growth 0/100, dividend 30/100. Its strongest factor is quality.
A038070 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $27.57M
- Revenue (TTM)
- $53.70M
- P/E
- 50.94
- EPS
- 83.03
- Dividend yield
- 2.12%
- Beta (5Y)
- 0.58
- 52-week high
- ₩7,760.09
- 52-week low
- ₩3,600.00
- Avg volume (3M)
- —
- Shares outstanding
- 9.03M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $265.79 | +0.48% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $442.24 | -0.36% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $148.77 | +1.38% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $552.85 | +0.96% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $833.56 | +0.61% |
| argenx SEENXTBR: ARGX | $64.17B | €879.20 | +1.74% |
| Moderna, Inc.NasdaqGS: MRNA | $63.41B | $158.83 | +14.36% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
Figures last refreshed Aug 18, 2026.